Neural Biomarkers in Fragile X Syndrome

Clinical trial NCT06957054 · COMPLETED

Trial details

NCT number: NCT06957054
Sponsor: Connecta Therapeutics, S.L.
Status: COMPLETED
Study type: OBSERVATIONAL

Fragile X Syndrome (FXS)Neurotypical Adults

Start date: 2024-12-16
Primary completion: 2025-03-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.